#Sorafenib is a cancer medication that interferes with the growth and spread of cancer cells in the body.
Sorafenib is used to treat #livercancer, #thyroidcancer, or a type of #kidneycancer called advanced renal cell carcinoma.
Sorafenib stops or slows the growth of cancer cells (tumors). It also works by slowing the growth of new blood vessels within the tumor.
Common side effects of Sorafenib include: weight loss, exfoliation of skin, hypophosphatemia, increased serum lipase, desquamation, hemorrhage, lymphocytopenia, pruritus, peripheral sensory neuropathy, headache, palmar-plantar erythrodysesthesia, fatigue, hypertension, diarrhea, arthralgia, skin rash, alopecia, neutropenia, increased amylase, and xeroderma.
This is not complete list. Consult your Doctor for a comprehensive list of adverse effects.
To make sure Sorafenib is safe for you, tell your doctor if you have:
Brand Name : Sorafenat
Active Ingredients : Sorafenib Tosylate
Manufactured by: Natco Pharma Ltd.
Strength: 200 mg
Packing: Pack of 120 Tablets
Sorafenib Cancer medicine is available with us under the brand name Sorafenat manufactured by Natco Pharma, we offer this Sorafenat Tablet at affordable prices to clients. Find Sorafenat 200 mg discounted price, its alternatives, shipping details by contacting us :-
QQ : email@example.com
Telephone: + 91-11-43526658
Mobile : +91-9873336444
Skype : Oddway2010
WeChat : Oddway2010
WhatsApp : +91-9873336444
Viber : +91-9873336444
Oddway International endeavours to ensure highest levels of client satisfaction. We follow ethical and sensible business policies helped us in securing a wide base of loyal and satisfied clients. Our motto is to build a long and healthy relationship with all the clients by offering genuine and effective medicines. Given the complexity of the diseases being treated with our medicines, we make sure that each consignment is delivered at economical rates within the stipulated time frame. We also supply our products worldwide including major countries USA, UK, China, Canada, Australia, Malaysia, Russia, Vietnam, Cambodia, Philippines, rest of the world.